Receptor Binding Properties of Neuraminidase for influenza A virus: An Overview of Recent Research Advances

References

• Ward MJ, Lycett SJ, Avila D, et al. Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza. BMC Evol Biol. 2013;13(1):222. doi: 10.1186/1471-2148-13-222
   PubMedGoogle Scholar
• Grassauer A, Egorov AY, Ferko B, et al. A host restriction-based selection system for influenza haemagglutinin transfectant viruses. J Gen Virol. 1998;79(Pt 6):1405–11. doi: 10.1099/0022-1317-79-6-1405
   PubMedGoogle Scholar
• Lin YP, Gregory V, Collins P, et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol. 2010;84(13):6769–6781. doi: 10.1128/JVI.00458-10
   PubMed Web of Science ®Google Scholar
• Medeiros R, Escriou N, Naffakh N, et al. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology. 2001;289(1):74–85. doi: 10.1006/viro.2001.1121
   PubMed Web of Science ®Google Scholar
• Mohr PG, Deng YM, McKimm-Breschkin JL. The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding. Virol J. 2015;12(1):67. doi: 10.1186/s12985-015-0295-3
   PubMedGoogle Scholar
• Benton DJ, Wharton SA, Martin SR, et al. Role of neuraminidase in influenza A(H7N9) virus receptor binding. J Virol. 2017;91(11): Virol 91. doi: 10.1128/JVI.02293-16
   Web of Science ®Google Scholar
• Du W, Guo H, Nijman VS, et al. The 2nd sialic acid-binding site of influenza a virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance. PLOS Pathog. 2019;15(6):e1007860. doi: 10.1371/journal.ppat.1007860
   PubMed Web of Science ®Google Scholar
• Wen F, Wan XF. Influenza neuraminidase: Underrated role in receptor binding. Trends Microbiol. 2019;27(6):477–479. doi: 10.1016/j.tim.2019.03.001
   PubMed Web of Science ®Google Scholar
• Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza a virus (S-OIV) H1N1 virus in humans. J Clin Virol. 2009;45(3):169–173. doi: 10.1016/j.jcv.2009.06.006
   PubMed Web of Science ®Google Scholar
• Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–1300. doi: 10.1016/S0140-6736(17)33293-2
   PubMed Web of Science ®Google Scholar
• Johnson NP, Mueller J. Updating the accounts: Global Mortality of the 1918-1920 “Spanish” influenza pandemic. Bulletin Of The History Of Medicine. 2002;76(1):105–115. doi: 10.1353/bhm.2002.0022
   PubMed Web of Science ®Google Scholar
• Taubenberger JK. The origin and virulence of the 1918 “Spanish” influenza virus. Proc Am Philos Soc. 2006;150:86–112. 1
   PubMed Web of Science ®Google Scholar
• Nayak DP, Balogun RA, Yamada H, et al. Influenza virus morphogenesis and budding. Virus Res. 2009;143(2):147–161. doi: 10.1016/j.virusres.2009.05.010
   PubMed Web of Science ®Google Scholar
• Wu Y, Wu Y, Tefsen B, et al. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 2014;22(4):183–191. doi: 10.1016/j.tim.2014.01.010
   PubMed Web of Science ®Google Scholar
• Shi Y, Wu Y, Zhang W, et al. Enabling the ‘host jump’: structural determinants of receptor-binding specificity in influenza a viruses. Nat Rev Microbiol. 2014;12(12):822–831. doi: 10.1038/nrmicro3362
   PubMed Web of Science ®Google Scholar
• Long JS, Mistry B, Haslam SM, et al. Host and viral determinants of influenza a virus species specificity. Nat Rev Microbiol. 2019;17(2):67–81. doi: 10.1038/s41579-018-0115-z
   PubMed Web of Science ®Google Scholar
• Ge S, Wang Z. An overview of influenza a virus receptors. Crit Rev Microbiol. 2011;37(2):157–165. doi: 10.3109/1040841X.2010.536523
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang D, Gao R, et al. Biological features of novel avian influenza a (H7N9) virus. Nature. 2013;499(7459):500–503. doi: 10.1038/nature12379
   PubMed Web of Science ®Google Scholar
• Bossart-Whitaker P, Carson M, Babu YS, et al. Three-dimensional structure of influenza a N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-Acetyl neuraminic acid. J Mol Biol. 1993;232(4):1069–1083. doi: 10.1006/jmbi.1993.1461
   PubMed Web of Science ®Google Scholar
• McAuley JL, Gilbertson BP, Trifkovic S, et al. Influenza virus neuraminidase structure and functions. Front Microbiol. 2019;10:39. doi: 10.3389/fmicb.2019.00039
   PubMed Web of Science ®Google Scholar
• Blok J, Air GM. Variation in the membrane-insertion and “stalk” sequences in eight subtypes of influenza type a virus neuraminidase. Biochemistry. 1982;21(17):4001–4007. doi: 10.1021/bi00260a015
   PubMed Web of Science ®Google Scholar
• Barman S, Adhikary L, Chakrabarti AK, et al. Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. J Virol. 2004;78(10):5258–5269. doi: 10.1128/JVI.78.10.5258-5269.2004
   PubMed Web of Science ®Google Scholar
• Ernst AM, Zacherl S, Herrmann A, et al. Differential transport of Influenza a neuraminidase signal anchor peptides to the plasma membrane. FEBS Lett. 2013;587(9):1411–1417. doi: 10.1016/j.febslet.2013.03.019
   PubMed Web of Science ®Google Scholar
• Colman PM, Varghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature. 1983;303(5912):41–44. doi: 10.1038/303041a0
   PubMed Web of Science ®Google Scholar
• Blumenkrantz D, Roberts KL, Shelton H, et al. The short stalk length of highly pathogenic avian influenza H5N1 virus neuraminidase limits transmission of pandemic H1N1 virus in ferrets. J Virol. 2013;87(19):10539–10551. doi: 10.1128/JVI.00967-13
   PubMed Web of Science ®Google Scholar
• Park S, Il Kim J, Lee I, et al. Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza a viruses. Sci Rep. 2017;7(1):10928. doi: 10.1038/s41598-017-11348-0
   PubMedGoogle Scholar
• Dai M, Du W, Martínez-Romero C, et al. Analysis of the evolution of pandemic influenza A(H1N1) virus neuraminidase reveals entanglement of different phenotypic characteristics. MBio. 2021;12: doi: 10.1128/mBio.00287-21
   Web of Science ®Google Scholar
• Matrosovich MN, Matrosovich TY, Gray T, et al. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol. 2004;78(22):12665–12667. doi: 10.1128/JVI.78.22.12665-12667.2004
   PubMed Web of Science ®Google Scholar
• Yang X, Steukers L, Forier K, et al. A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus. PLoS One. 2014;9(10):e110026. doi: 10.1371/journal.pone.0110026
   PubMed Web of Science ®Google Scholar
• Wagner R, Matrosovich M, Klenk HD. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol. 2002;12(3):159–166. doi: 10.1002/rmv.352
   PubMed Web of Science ®Google Scholar
• Li Y, Cao H, Dao N, et al. High-throughput neuraminidase substrate specificity study of human and avian influenza a viruses. Virology. 2011;415(1):12–19. doi: 10.1016/j.virol.2011.03.024
   PubMed Web of Science ®Google Scholar
• Webster RG, Air GM, Metzger DW, et al. Antigenic structure and variation in an influenza virus N9 neuraminidase. J Virol. 1987;61(9):2910–2916. doi: 10.1128/jvi.61.9.2910-2916.1987
   PubMed Web of Science ®Google Scholar
• Ohuchi M, Asaoka N, Sakai T, et al. Roles of neuraminidase in the initial stage of influenza virus infection. Microbes Infect. 2006;8(5):1287–1293. doi: 10.1016/j.micinf.2005.12.008
   PubMed Web of Science ®Google Scholar
• Sakai T, Nishimura SI, Naito T, et al. Influenza a virus hemagglutinin and neuraminidase act as novel motile machinery. Sci Rep. 2017;7(1):45043. doi: 10.1038/srep45043
   PubMedGoogle Scholar
• Guo H, Rabouw H, Slomp A, et al. Kinetic analysis of the influenza a virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces. PLOS Pathog. 2018;14(8):e1007233. doi: 10.1371/journal.ppat.1007233
   PubMed Web of Science ®Google Scholar
• Laver WG, Colman PM, Webster RG, et al. Influenza virus neuraminidase with hemagglutinin activity. Virology. 1984;137(2):314–323. doi: 10.1016/0042-6822(84)90223-X
   PubMed Web of Science ®Google Scholar
• Nuss JM, Air GM. Transfer of the hemagglutinin activity of influenza virus neuraminidase subtype N9 into an N2 neuraminidase background. Virology. 1991;183(2):496–504. doi: 10.1016/0042-6822(91)90979-L
   PubMed Web of Science ®Google Scholar
• Air GM, Laver WG. Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity. Virology. 1995;211(1):278–284. doi: 10.1006/viro.1995.1401
   PubMed Web of Science ®Google Scholar
• Varghese JN, Colman PM, van Donkelaar A, et al. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc Natl Acad Sci U S A. 1997;94(22):11808–11812. doi: 10.1073/pnas.94.22.11808
   PubMed Web of Science ®Google Scholar
• Elli S, Gambacorta N, Rudd TR, et al. MD simulation of the interaction between sialoglycans and the second sialic acid binding site of influenza a virus N1 neuraminidase. Biochem J. 2021;478(2):423–441. doi: 10.1042/BCJ20200670
   PubMed Web of Science ®Google Scholar
• Hausmann J, Kretzschmar E, Garten W, et al. N1 neuraminidase of influenza virus A/FPV/Rostock/34 has haemadsorbing activity. J Gen Virol. 1995;76(Pt 7):1719–1728. doi: 10.1099/0022-1317-76-7-1719
   PubMedGoogle Scholar
• Kobasa D, Rodgers ME, Wells K, et al. Neuraminidase hemadsorption activity, conserved in avian influenza a viruses, does not influence viral replication in ducks. J Virol. 1997;71(9):6706–6713. doi: 10.1128/jvi.71.9.6706-6713.1997
   PubMed Web of Science ®Google Scholar
• Du W, Dai M, Li Z, et al. Substrate binding by the second sialic acid-binding site of influenza a virus N1 neuraminidase contributes to enzymatic activity. J Virol. 2018;92(20). doi: 10.1128/JVI.01243-18
   Web of Science ®Google Scholar
• Sung JC, Van Wynsberghe AW, Amaro RE, et al. Role of secondary sialic acid binding sites in influenza N1 neuraminidase. J Am Chem Soc. 2010;132(9):2883–2885. doi: 10.1021/ja9073672
   PubMed Web of Science ®Google Scholar
• Du W, de Vries E, van Kuppeveld FJM, et al. Second sialic acid-binding site of influenza a virus neuraminidase: binding receptors for efficient release. FEBS J. 2021;288:5598–5612. doi: 10.1111/febs.15668
   PubMed Web of Science ®Google Scholar
• Dai M, McBride R, Dortmans J, et al. Mutation of the second sialic acid-binding site, resulting in reduced neuraminidase activity, preceded the emergence of H7N9 influenza a virus. J Virol 91. 2017;91(9). doi: 10.1128/JVI.00049-17
   Google Scholar
• Liu M, Huang LZX, Smits AA, et al. Human-type sialic acid receptors contribute to avian influenza a virus binding and entry by hetero-multivalent interactions. Nat Commun. 2022;13:4054. doi: 10.1038/s41467-022-31840-0
   PubMed Web of Science ®Google Scholar
• Matrosovich MN, Krauss S, Webster RG. H9N2 influenza a viruses from poultry in asia have human virus-like receptor specificity. Virology. 2001;281(2):156–162. doi: 10.1006/viro.2000.0799
   PubMed Web of Science ®Google Scholar
• Uhlendorff J, Matrosovich T, Klenk HD, et al. Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses. Arch Virol. 2009;154(6):945–957. doi: 10.1007/s00705-009-0393-x
   PubMed Web of Science ®Google Scholar
• Hooper KA, Bloom JD. A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein. J Virol. 2013;87(23):12531–12540. doi: 10.1128/JVI.01889-13
   PubMed Web of Science ®Google Scholar
• Hooper KA, Crowe JE Jr., Bloom JD, et al. Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice. J Virol. 2015;89(7):3737–3745. doi: 10.1128/JVI.00012-15
   PubMed Web of Science ®Google Scholar
• Chen TH, Chen CC, Wu SC. Neuraminidase (NA) 370-loop mutations of the 2009 pandemic H1N1 viruses affect NA enzyme activity, hemagglutination titer, mouse virulence, and inactivated-virus immunogenicity. Viruses. 2022;14(6):1304. Viruses 14. doi: 10.3390/v14061304
   PubMed Web of Science ®Google Scholar
• Koel BF, Burke DF, Bestebroer TM, et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science. 2013;342(6161):976–979. doi: 10.1126/science.1244730
   PubMed Web of Science ®Google Scholar
• Parker L, Wharton SA, Martin SR, et al. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza a (H3N2) vaccine viruses. J Gen Virol. 2016;97(6):1333–1344. doi: 10.1099/jgv.0.000457
   PubMedGoogle Scholar
• Lu B, Zhou H, Chan W, et al. Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs. Vaccine. 2006;24(44–46):6691–6693. doi: 10.1016/j.vaccine.2006.05.062
   PubMed Web of Science ®Google Scholar
• Nobusawa E, Ishihara H, Morishita T, et al. Change in receptor-binding specificity of recent human influenza a viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology. 2000;278(2):587–596. doi: 10.1006/viro.2000.0679
   PubMed Web of Science ®Google Scholar
• Gulati S, Smith DF, Cummings RD, et al. Human H3N2 influenza viruses isolated from 1968 to 2012 show varying preference for receptor substructures with no apparent consequences for disease or spread. PLoS One. 2013;8(6):e66325. doi: 10.1371/journal.pone.0066325
   PubMed Web of Science ®Google Scholar
• Mögling R, Richard MJ, Vliet SV, et al. Neuraminidase-mediated haemagglutination of recent human influenza A(H3N2) viruses is determined by arginine 150 flanking the neuraminidase catalytic site. J Gen Virol. 2017;98(6):1274–1281. doi: 10.1099/jgv.0.000809
   PubMed Web of Science ®Google Scholar
• Zhu X, McBride R, Nycholat CM, et al. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors. J Virol. 2012;86(24):13371–13383. doi: 10.1128/JVI.01426-12
   PubMed Web of Science ®Google Scholar
• Xue KS, Greninger AL, Pérez-Osorio A, et al. Cooperating H3N2 influenza virus variants are not detectable in primary clinical samples. mSphere. 2018;3(1). doi: 10.1128/mSphereDirect.00552-17
   Web of Science ®Google Scholar
• Brown JC, Barclay WS, Galiano M, et al. Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding. J Gen Virol. 2020;101(5):456–466. doi: 10.1099/jgv.0.001348
   PubMed Web of Science ®Google Scholar
• Almayahi ZK, Al Kindi H, Davies CT, et al. First report of human infection with avian influenza A(H9N2) virus in Oman: The need for a one health approach. Int J Infect Dis. 2020;91:169–173. doi: 10.1016/j.ijid.2019.11.020
   PubMed Web of Science ®Google Scholar
• Bi Y, Mei K, Shi W, et al. Two novel reassortants of avian influenza a (H5N6) virus in China. J Gen Virol. 2015;96(5):975–981. doi: 10.1099/vir.0.000056
   PubMedGoogle Scholar
• Zhang H, de Vries RP, Tzarum N, et al. A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors. Cell Host Microbe. 2015;17:377–384. doi: 10.1016/j.chom.2015.02.006
   PubMed Web of Science ®Google Scholar
• de Vries E, Du W, Guo H, et al. Influenza a virus hemagglutinin–neuraminidase–receptor balance: Preserving virus motility. Trends Microbiol. 2020;28(1):57–67. doi: 10.1016/j.tim.2019.08.010
   PubMed Web of Science ®Google Scholar
• Du W, Wolfert MA, Peeters B, et al. Mutation of the second sialic acid-binding site of influenza a virus neuraminidase drives compensatory mutations in hemagglutinin. PLOS Pathog. 2020;16:e1008816. doi: 10.1371/journal.ppat.1008816
   PubMed Web of Science ®Google Scholar
• An SH, Son SE, Song JH, et al. Selection of an optimal recombinant egyptian H9N2 avian influenza vaccine strain for poultry with high antigenicity and safety. Vaccines (Basel). 2022;10(2):162. doi: 10.3390/vaccines10020162
   PubMed Web of Science ®Google Scholar
• Scheibner D, Salaheldin AH, Bagato O, et al. Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza a viruses. PLOS Pathog. 2023;19(2):e1011135. doi: 10.1371/journal.ppat.1011135
   PubMed Web of Science ®Google Scholar